August 24, 2016 4:06 PM ET

Biotechnology

Company Overview of Cubist Pharmaceuticals LLC

Company Overview

Cubist Pharmaceuticals LLC, a biopharmaceutical company, is engaged in the research, development, and commercialization of pharmaceutical products for medical needs in the acute care environment in the United States. It offers CUBICIN (daptomycin for injection), a once-daily, bactericidal, intravenous antibiotic with activity against methicillin-resistant Staphylococcus aureus; DIFICID for the treatment of clostridium difficile-associated diarrhea (CDAD); and ENTEREG (alvimopan), an oral peripherally-acting mu opioid receptor antagonist to accelerate upper and lower gastrointestinal recovery. The company also develops Tedizolid Phosphate, a novel antibiotic product candidate for the treatmen...

65 Hayden Avenue

Lexington, MA 02421

United States

Founded in 1992

873 Employees

Phone:

781-860-8660

Key Executives for Cubist Pharmaceuticals LLC

Chief Operating Officer and Executive Vice President
Age: 53
Chief Compliance Officer and Senior Vice President of Global Compliance & Risk
Senior Vice President of Scientific Affairs
Age: 68
Senior Vice President of Discovery and Pharmaceutical Sciences
Chief Intellectual Property Counsel, Head of Litigation and Vice President
Compensation as of Fiscal Year 2016.

Cubist Pharmaceuticals LLC Key Developments

Cubist Pharmaceuticals Inc. Presents at Boston CEO Conference, May-26-2015 through May-27-2015

Cubist Pharmaceuticals Inc. Presents at Boston CEO Conference, May-26-2015 through May-27-2015. Venue: Four Seasons Hotel, 200 Boylston Street, Boston, MA 02116, United States. Presentation Date & Speakers: May-26-2015, Rob Perez. May-27-2015, Rob Perez.

Cubist Pharmaceuticals Files Form 15

Cubist Pharmaceuticals, Inc. has announced that it has filed a Form 15 with the Securities and Exchange Commission to voluntarily deregister its Common Stock, $0.001 par value under the Securities Exchange Act of 1934, as amended.

Cubist Pharmaceuticals Inc.(NasdaqGM:CBST) dropped from MSCI Acwi + Frontier Markets(acwi Fm) All Cap Index

Cubist Pharmaceuticals Inc.(NasdaqGM:CBST) dropped from MSCI Acwi + Frontier Markets(acwi Fm) All Cap Index

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Cubist Pharmaceuticals LLC, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.